Selleckchem Inc

Bio Active Compounds.

Recent products

Obinutuzumab (anti-CD20)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Cemiplimab (anti-PD-1)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Tremelimumab (anti-CTLA-4)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Denosumab (anti-RANK ligand)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Infliximab (anti-TNF-alpha)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Panitumumab (anti-EGFR)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Spartalizumab (anti-PD-1)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Camrelizumab (anti-PD-1)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Avelumab (anti-PD-L1)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Durvalumab (anti-PD-L1)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Tocilizumab (anti-IL-6R)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Sarilumab (anti-IL-6R?)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Adalimumab (anti-TNF-alpha)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Rituximab (anti-CD20)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Pertuzumab (anti-HER2)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Trastuzumab (anti-HER2)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

1 703 704 705